microdosing tirzepatide GLP-1 is popular, but there's little evidence it works FITISH GLP-1 MICRODOSING PROGRAM

Kidney outcomes with glucagonlike peptide1 receptor agonists in patients with type 2 diabetes

Pharmacological dual incretin receptor agonist therapies utilize effects on glucagon secretion that are of clinical importance in antidiabetic regimens

IDF Diabetes Atlas, 11th Edition

If you're navigating your GLP-1 medication journey , you've probably discovered that finding the right foods can feel like solving a complex puzzle

TEXT ON-SCREEN: PREP, CHECK, SELECT, INJECT

- to reduce excess body weight and maintain weight reduction long term in: adults and pediatric patients aged 12 years and older with obesity adults with overweight in the presence of at least one weight-related comorbid condition